# Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast Cancer

> **NCT07289282** · — · RECRUITING · sponsor: **Atlas University** · enrollment: 80 (estimated)

## Conditions studied

- Breast Cancer
- Neoadjuvant Therapy
- Pathological Response
- Invasive Breast Carcinoma
- MicroRNAs

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07289282
- **Lead sponsor:** Atlas University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2026-08
- **Final completion:** 2026-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07289282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07289282, "Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07289282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*